Wogonin inhibits microglial cell migration via suppression of nuclear factor-kappa B activity

International Immunopharmacology

Volumn 8, Issue 12, 2008, Pages 1658-1662

  Piao, Hua Zi ^a   Choi, In Young ^b   Park, Jin Sun ^c   Kim, Hee Sun ^c   Cheong, Jae Hoon ^d   Son, Kun Ho ^e   Jeon, Su Jin ^e   Ko, Kwang Ho ^f   Kim, Won Ki ^b  

^a YANBIAN UNIVERSITY   (China)

^b Kyung Hee University Hospital   (South Korea)

^c Ewha Womans University School of Medicine   (South Korea)

^d Sahmyook University   (South Korea)

^e Andong National University   (South Korea)

^f Seoul National University   (South Korea)

Author keywords

cAMP; MCP 1; Microglia; Migration; NF B; Wogonin

Indexed keywords

ACETYLCYSTEINE; CHEMOKINE; CYCLIC AMP; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; PYRROLIDINE DITHIOCARBAMATE; WOGONIN;

ANIMAL CELL; ARTICLE; CELL MIGRATION; CELL MOTILITY; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; MICROGLIA; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

ANIMALS; CELL MOVEMENT; CHEMOKINE CCL2; CHEMOKINE CCL5; CYCLIC AMP; DRUGS, CHINESE HERBAL; FLAVANONES; MICROGLIA; NF-KAPPA B; RATS; RATS, SPRAGUE-DAWLEY; SCUTELLARIA;

EID: 54549104761     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2008.07.018     Document Type: Article

References (40)

1. Middleton Jr. E., Kandaswami C., and Theoharides T.C. The effects of plant flavonoids on mammalian cells: implication for inflammation, heart disease, and cancer. Pharmacol Rev 52 (2000) 673-751
2. Chen Y.C., Shen S.C., Chen L.G., Lee T.J., and Yang L.L. Wogonin, baicalin, and baicalein inhibition of inducible nitric oxide synthase and cyclooxygenase-2 gene expressions induced by nitric oxide synthase inhibitors and lipopolysaccharide. Biochem Pharmacol 61 (2001) 1417-1427
3. Nakamura N., Hayasaka S., Zhang X.Y., Nagaki Y., Matsumoto M., et al. Effects of baicalin, baicalein, and wogonin on interleukin-6 and interleukin-8 expression, and nuclear factor-kappaB binding activities induced by interleukin-1beta in human retinal pigment epithelial cell line. Exp Eye Res 77 (2003) 195-202
4. Suk K., Lee H., Kang S.S., Cho G.J., and Choi W.S. Flavonoid baicalein attenuates activation-induced cell death of brain microglia. J Pharmacol Exp Ther 305 (2003) 638-645
5. Wakabayashi I., and Yasui K. Wogonin inhibits inducible prostaglandin E (2) production in macrophages. Eur J Pharmacol 406 (2000) 477-481
6. Chi Y.S., Cheon B.S., and Kim H.P. Effect of wogonin, a plant flavone from Scutellaria radix, on the suppression of cyclooxygenase-2 and the induction of inducible nitric oxide synthase in lipopolysaccharide-treated RAW 264.7 cells. Biochem Pharmacol 61 (2001) 1195-1203
7. Lee H., Kim Y.O., Kim H., Kim S.Y., Noh H.S., et al. Flavonoid wogonin from medicinal herb is neuroprotective by inhibiting inflammatory activation of microglia. FASEB J 17 (2003) 1943-1944
8. Chun W., Lee H.J., Kong P.J., Lee G.H., Cheong I.Y., et al. Synthetic wogonin derivatives suppress lipopolysaccharide-induced nitric oxide production and hydrogen peroxide-induced cytotoxicity. Arch Pharm Res 28 (2005) 216-219
9. Chang Y.L., Shen J.J., Wung B.S., Cheng J.J., and Wang D.L. Chinese herbal remedy wogonin inhibits monocyte chemotactic protein-1 gene expression in human endothelial cells. Mol Pharmacol 60 (2001) 507-513
10. Piao H.Z., Jin S.A., Chun H.S., Lee J.C., and Kim W.K. Neuroprotective effect of wogonin: potential roles of inflammatory cytokines. Arch Pharm Res 27 (2004) 930-936
11. Cho J., and Lee H.K. Wogonin inhibits ischemic brain injury in a rat model of permanent middle cerebral artery occlusion. Biol Pharm Bull 27 (2004) 1561-1564
12. Dirnagl U., Iadecola C., and Moskowitz M.A. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 22 (1999) 391-397
13. Lee J.C., Cho G.S., Kim H.J., Lim J.H., Oh Y.K., et al. Accelerated cerebral ischemic injury by activated macrophages/microglia after lipopolysaccharide microinjection into rat corpus callosum. Glia 50 (2005) 168-181
14. Zhang Z., Chopp M., and Powers C. Temporal profile of microglial response following transient (2 h) middle cerebral artery occlusion. Brain Res 744 (1997) 189-198
15. Stence N., Waite M., and Dailey M.E. Dynamics of microglial activation. Glia 33 (2001) 256-266
16. Danton G.H., and Dietrich W.D. Inflammatory mechanisms after ischemia and stroke. J Neuropathol Exp Neurol 62 (2003) 127-136
17. Franklin A., Parmentier-Batteur S., Walter L., Greenberg D.A., and Stella N. Palmitoylethanolamide increases after focal cerebral ischemia and potentiates microglial cell motility. J Neurosci 23 (2003) 7767-7775
18. Lim C.M., Chang H., Chen Y.H., Li S.Y., Wu I.H., et al. Protective role of wogonin against lipopolysaccharide-induced angiogenesis via VEGFR-2, not VEGFR-1. Int Immunopharmacol 6 (2006) 1690-1698
19. Shen S.C., Lin C.W., Lee H.M., Chien L.L., and Chen Y.C. Lipopolysaccharide plus 12-o-tetradecanoylphorbol 13-acetate induction of migration and invasion of glioma cells in vitro and in vivo: differential inhibitory effects of flavonoids. Neuroscience 140 (2006) 477-489
20. Jin Y., Lee J.C., Choi I.Y., Kim E.A., Shin M.H., et al. Excretory-secretory products produced by paragonimus westermani differentially regulate the nitric oxide production and viability of microglial cells. Int Arch Allergy Immunol 139 (2006) 16-24
21. Ullrich O., Diestel A., Eyupoglu I.Y., and Nitsch R. Regulation of microglial expression of integrins by oly(ADP-ribose)polymerase-1. Nat Cell Biol 3 (2001) 1035-1042
22. Zheng Z., and Yenari M.A. Post-ischemic inflammation: molecular mechanisms and therapeutic implications. Neurol Res 26 (2004) 884-892
23. Nasu-Tada K., Koizumi S., and Inoue K. Involvement of beta1 integrin in microglial chemotaxis and proliferation on fibronectin: different regulations by ADP through PKA. Glia 52 (2005) 98-107
24. Liu B., and Hong J.S. Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention. J Pharmacol Exp Ther 304 (2003) 1-7
25. Giulian D., and Vaca K. Inflammatory glia mediate delayed neuronal damage after ischemia in the central nervous system. Stroke 24 12 Suppl (1993) I84-I90
26. Lees G.J. The possible contribution of microglia and macrophages to delayed neuronal death after ischemia. J Neurol Sci 114 (1993) 119-122
27. Kim W.K., and Ko K.H. Potentiation of N-methyl-d-aspartate-mediated neurotoxicity by immunostimulated murine microglia. J Neurosci Res 54 (1998) 17-26
28. Hewett S.J., Muir J.K., Lobner D., Symons A., and Choi D.W. Potentiation of oxygen-glucose deprivation-induced neuronal death after induction of iNOS. Stroke 27 (1996) 1586-1591
29. Kim W.K., Seo D.O., Choi J.J., and Ko K.H. Immunostimulated glial cells potentiate glucose deprivation-induced death of cultured rat cerebellar granule cells. J Neurotrauma 16 (1999) 415-424
30. Yrjanheikki J., Tikka T., Keinanen R., Goldsteins G., Chan P.H., et al. A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc Natl Acad Sci U S A 96 (1999) 13496-13500
31. Gong X., and Sucher N.J. Stroke therapy in traditional Chinese medicine (TCM): prospects for drugdiscovery and development. Trends Pharmacol Sci 20 (1999) 191-196
32. Wang Z., Castresana M.R., and Newman W.H. NF-kappaB is required for TNF-alpha-directed smooth muscle cell migration. FEBS Lett 508 (2001) 360-364
33. Strauch E.D., Bass B.L., Rao J.N., Vann J.A., and Wang J.Y. NF-kappaB regulates intestinal epithelial cell and bile salt-induced migration after injury. Ann Surg 237 (2003) 494-501
34. Lee S.O., Jeong Y.J., Yu M.H., Lee J.W., Hwangbo M.H., Kim C.H., et al. Wogonin suppresses TNF-alpha-induced MMP-9 expression by blocking the NF-kappaB activation via MAPK signaling pathways in human aortic smooth muscle cells. Biochem Biophys Res Commun 351 (2006) 118-125
35. Lin C.M., Chang H., Chen Y.H., Wu I.H., and Chiu J.H. Wogonin inhibits IL-6-induced angiogenesis via down-regulation of VEGF and VEGFR-1, not VEGFR-2. Planta Med 72 (2006) 1305-1310
36. Fas S.C., Baumann S., Zhu J.Y., Giaisi M., Treiber M.K., Mahlknecht U., et al. Wogonin sensitizes resistant malignant cells to TNFalpha- and TRAIL-induced apoptosis. Blood 108 (2006) 3700-3706
37. Nakamura N., Hayasaka S., Zhang X.Y., Nagaki Y., Matsumoto M., Hayasaka Y., et al. Effects of baicalin, baicalein, and wogonin on interleukin-6 and interleukin-8 expression, and nuclear factor-kappab binding activities induced by interleukin-1beta in human retinal pigment epithelial cell line. Exp Eye Res 77 (2003) 195-202
38. Kim H., Kim Y.S., Kim S.Y., and Suk K. The plant flavonoid wogonin suppresses death of activated C6 rat glial cells by inhibiting nitric oxide production. Neurosci Lett 309 (2001) 67-71
39. Huang C., Jacobson K., and Schaller M.D. MAP kinases and cell migration. J Cell Sci 117 (2004) 4619-4628
40. Milan J., Charalambous C., Elhag R., Chen T.C., Li W., et al. Multiple signaling pathways are involved in endothelin-1-induced brain endothelial cell migration. Am J Physiol Cell Physiol 291 (2006) C155-C164